GE HealthCare (GEHC) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $1.13
- EPS estimate
- $1.04
- EPS surprise
- +9.08%
- Revenue surprise
- +0.59%
- Revenue
- $5.3B
- Revenue estimate
- $5.3B
- Reported
- Jul 29, 2026
GE HealthCare reported Q2 2026 results on July 29, 2026. Earnings per share were $1.13, ahead of the $1.04 estimate by 9.08%. Revenue was $5.3 billion, 0.59% above the consensus, also shown as $5.3 billion. Compared with Q2 2025, EPS rose about 6.6% from $1.06 and revenue rose about 6% from $5.0 billion.
The longer record shows modest growth. Annual EPS rose from $3.94 in 2023 to $4.49 in 2024, up about 14%, and to $4.58 in 2025, up about 2%. The first half of 2026 adds up to $2.12, about 2.4% more than the same period a year earlier. Q4 was the strongest quarter for EPS in each full year in the table. Q4 2024 set the EPS high at $1.45, and Q4 2025 set the revenue high at $5.7 billion. Of the 14 quarters with an estimate in the table, GE HealthCare beat 12. The two misses were Q1 2024, at 0.75% below, and Q1 2026, at 5.70% below.
GE HealthCare reported Q3 results between October 29 and October 31 in each of the past three years. That points to late October 2026 for the next report. It will show whether the year-over-year growth of Q2 continues.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 29, 2026 | $1.04 | $1.13 | +9.08% | $5.3B | SEC |
| Q1 2026 | Apr 29, 2026 | $1.05 | $0.99 | −5.70% | $5.1B | SEC |
| Q4 2025 | Feb 4, 2026 | $1.40 | $1.44 | +2.97% | $5.7B | SEC |
| Q3 2025 | Oct 29, 2025 | $1.05 | $1.07 | +2.27% | $5.1B | SEC |
| Q2 2025 | Jul 30, 2025 | $0.92 | $1.06 | +15.51% | $5.0B | SEC |
| Q1 2025 | Apr 30, 2025 | $0.91 | $1.01 | +10.53% | $4.8B | SEC |
| Q4 2024 | Feb 13, 2025 | $1.26 | $1.45 | +14.78% | $5.3B | SEC |
| Q3 2024 | Oct 30, 2024 | $1.05 | $1.14 | +8.31% | $4.9B | SEC |
| Q2 2024 | Jul 31, 2024 | $0.98 | $1.00 | +2.36% | $4.8B | SEC |
| Q1 2024 | Apr 30, 2024 | $0.91 | $0.90 | −0.75% | $4.7B | SEC |
| Q4 2023 | Feb 6, 2024 | $1.07 | $1.18 | +10.23% | $5.2B | SEC |
| Q3 2023 | Oct 31, 2023 | $0.90 | $0.99 | +10.37% | $4.8B | SEC |
| Q2 2023 | Jul 25, 2023 | $0.87 | $0.92 | +5.84% | $4.8B | SEC |
| Q1 2023 | Apr 25, 2023 | $0.79 | $0.85 | +7.26% | $4.7B | SEC |
| Q4 2022 | Jan 30, 2023 | $0.00 | $1.31 | +0.00% | $4.9B | SEC |
Quarterly revenue
Frequently asked questions
When did GE HealthCare (GEHC) last report earnings?
GE HealthCare last reported on Jul 29, 2026, covering fiscal Q2 2026.
Did GEHC beat earnings estimates?
Yes. GE HealthCare reported EPS of $1.13 for Q2 2026 against a $1.04 estimate — a 9.08% beat.
How much revenue did GEHC report last quarter?
GE HealthCare reported $5.3B in revenue for Q2 2026, against a consensus estimate of $5.3B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.